SCHEDULE 13G/A: Great Point Partners and Affiliates Disclose 4.86% Passive Stake in ZURA BIO LIMITED
Beneficial Ownership Report
Great Point Partners, LLC, along with Dr. Jeffrey R. Jay, M.D., and Ms. Lillian Nordahl, have jointly reported a beneficial ownership of 4.86% of ZURA BIO LIMITED's Class A Ordinary Shares as of December 31, 2024.
Summary
- Great Point Partners, LLC, Dr. Jeffrey R. Jay, M.D., and Ms. Lillian Nordahl, collectively referred to as the Reporting Persons, have filed an Amendment No. 3 to Schedule 13G.
- As of December 31, 2024, the Reporting Persons beneficially own an aggregate of 3,170,194 Class A Ordinary Shares of ZURA BIO LIMITED.
- This ownership represents 4.86% of the total Class A Ordinary Shares outstanding, based on 65,293,530 shares reported by ZURA BIO LIMITED in its Form 10-Q filed on November 7, 2024.
- The Reporting Persons share both voting and dispositive power over all 3,170,194 shares.
- The filing indicates that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain qualitative information that would significantly sway sentiment positively or negatively regarding the company's operations or prospects.
Positives
- The filing indicates continued passive institutional interest in ZURA BIO LIMITED by Great Point Partners, LLC and its affiliates.
Negatives
- The document is a routine ownership disclosure and does not contain information regarding company performance or operational negatives.
Risks
- NA
Future Outlook
This document is a beneficial ownership report and does not contain forward-looking statements or guidance from the issuer.
Industry Context
This filing reflects a passive investment stake by an institutional investor in a publicly traded company, a common occurrence in the financial markets. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant passive institutional ownership, which can be viewed as a vote of confidence by some investors.
Key Dates
| Date | Description |
|---|---|
| 2024-11-07 | Date ZURA BIO LIMITED filed its Form 10-Q, reporting 65,293,530 shares outstanding, which was used as the basis for percentage calculation. |
| 2024-12-31 | Date of event which requires the filing of this statement (beneficial ownership snapshot date). |
| 2025-02-14 | Date of the Joint Filing Agreement between the Reporting Persons. |
| 2025-02-14 | Date the Schedule 13G Amendment No. 3 was signed and filed. |
Keywords
ZURA BIO LIMITED, G9TY5A101, Schedule 13G, Beneficial Ownership, Great Point Partners, Institutional Investor, SEC Filing, Class A Ordinary Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.